Gerard Ber Y M Abs Therapeutics, Inc. (YMAB) insider trading activity

YMAB Quotes by TradingView

Gerard Ber is Director of Y-mAbs Therapeutics, Inc.. Currently has a direct ownership of 1,608 shares of YMAB, which is worth approximately $22,270. The most recent transaction as insider was on Jun 10, 2024, when has been sold 722 shares (Common Stock) at a price of $12.0 per share, resulting in proceeds of $8,664. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.61K
30.99% 3M change
30.99% 12M change
Total Value Held $22,270

Gerard Ber Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 10 2024
SELL
Open market or private sale
$8,664 $12.0 p/Share
722 Reduced 30.99%
1,608 Common Stock
Jun 08 2023
BUY
Grant, award, or other acquisition
-
2,330 Added 50.0%
2,330 Common Stock

Also insider at

LNTH
Lantheus Holdings, Inc. Healthcare
GB

Gerard Ber

Director
New York, NY

Track Institutional and Insider Activities on YMAB

Follow Y-mAbs Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells YMAB shares.

Notify only if

Insider Trading

Get notified when an Y M Abs Therapeutics, Inc. insider buys or sells YMAB shares.

Notify only if

News

Receive news related to Y-mAbs Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on YMAB